Haemonetics Corp Share Price Today: Live Updates & Key Insights
Haemonetics Corp share price today is $78.78, up 1.78%. The stock opened at $78.32 against the previous close of $77.4, with an intraday high of $79.4 and low of $77.67.
Haemonetics Corp Share Price Chart
Haemonetics Corp
Haemonetics Corp Share Price Performance
Haemonetics Corp Institutional Holdings
Haemonetics Corp Market Status
Haemonetics Corp Fundamentals
Market Cap 3517.52 M
PB Ratio 4.4532
PE Ratio 37.9412
Enterprise Value 4525.29 M
Total Assets 2395.93 M
Volume 462740
Haemonetics Corp Company Financials
About Haemonetics Corp & investment objective
Company Information Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. The company also offers treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that measures fractional flow reserve and diastolic pressure ratio, as well as fiber optic sensor solutions used in medical devices and other critical industrial applications. In addition, it provides hospital products comprising TEG 6s system, smallest cartridge-based viscoelastic analyzer that provides a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, the company offers Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries;vascular closure products comprise VASCADE 5F, VASCADE 6/7F, VASCADE MVP XL, and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen; and transfusion management solutions. It sells its products through direct sales force and independent distributors. The company was founded in 1971 and is headquartered in Boston, Massachusetts.
Organisation Medical Devices
Employees 3009
Industry Medical Devices
CEO Mr. Christopher A. Simon
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Haemonetics Corp FAQs
What is the share price of Haemonetics Corp today?
The current share price of Haemonetics Corp is $78.78.
Can I buy Haemonetics Corp shares in India?
Yes, Indian investors can buy Haemonetics Corp shares by opening an international trading and demat account with Motilal Oswal.
How to buy Haemonetics Corp shares in India?
You can easily invest in Haemonetics Corp shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Haemonetics Corp shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Haemonetics Corp.
Can I buy fractional shares of Haemonetics Corp?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Haemonetics Corp?
Haemonetics Corp has a market cap of $3517.52 M.
In which sector does Haemonetics Corp belong?
Haemonetics Corp operates in the Medical Devices sector.
What documents are required to invest in Haemonetics Corp stocks?
To invest, you typically need:
What is the PE and PB ratio of Haemonetics Corp?
The PE ratio of Haemonetics Corp is 37.94 and the PB ratio is 4.45.